FDA grants temporary labeling flexibility for non-allergen minor ingredients
With many food manufacturers experiencing difficulties in sourcing some ingredients during the pandemic, the FDA is allowing temporary flexibility in food labeling requirements enabling them to make minor formulation changes without updating labels, provided they are not introducing allergens or foods known to cause sensitivities.
The goal «is to provide regulatory flexibility, where appropriate, to help minimize the impact of supply chain disruptions on product availability associated with the current COVID-19 pandemic», said the FDA in a guidance document (pdf)issued on 22 May 2020.
Zur entsprechenden temporären Flexibilisierung im schweizerischen Lebensmittelrecht, siehe News vom 17. April 2020